Results 261 to 270 of about 281,573 (395)

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.

Journal of Clinical Oncology, 2017
C. Turtle, K. Hay, L. Hanafi, Daniel H. Li, S. Cherian, Xueyan Chen, B. Wood, A. Lozanski, J. Byrd, S. Heimfeld, S. Riddell, D. Maloney   +11 more
semanticscholar   +1 more source

Chronic Lymphocytic Leukemia

CA: A Cancer Journal for Clinicians, 1989
openaire   +3 more sources

Patient‐derived xenograft models in pan‐cancer: From bench to clinic

Interdisciplinary Medicine, EarlyView.
Abstract Patient‐derived xenograft (PDX) models provide a robust preclinical platform that preserves the genetic and phenotypic heterogeneity of patient tumors while mirroring their tumor genetic characteristics, which retain malignant cells and the tumor pathological structure, making them valuable for studying tumor progression and developing ...
Jiatong Li, Ao Gu, Nannan Tang, Gokhan Zengin, Meng‐Yao Li, Yingbin Liu   +5 more
wiley   +1 more source

A Rare Case of Chronic Lymphocytic Leukemia Complicated by Myasthenia Gravis. [PDF]

J Community Hosp Intern Med Perspect
Khan E, Ilyas R, Shah S, Jiwani R, Samhouri Y, Khan C.   +5 more
europepmc   +1 more source

Decreased actin content of lymphocytes from patients with chronic lymphocytic leukemia [PDF]

, 1982
R Stark, LF Liebes, D Nevrla, M Conklyn, R Silber   +4 more
openalex   +1 more source

Advanced single‐cell RNA sequencing in tumor immunology

Interdisciplinary Medicine, EarlyView.
This review highlights the applications of advanced single‐cell RNA sequencing (scRNA‐seq) technologies in tumor immunology. It summarizes representative scRNA‐seq methods according to technical principles, with a focus on single‐cell T cell receptor sequencing. This review also discusses how scRNA‐seq is used to construct immune cell atlases of tumors,
Yilong Liu, Xiyuan Yu, Zhipeng Han, Qiuyang Wei, Qi Niu, Chaoyong Yang, Jie P. Li, Zijian Guo, Huimin Zhang   +8 more
wiley   +1 more source

Bruton's Tyrosine Kinase (BTK) Mutations in Chronic Lymphocytic Leukemia (CLL): A Clinical View. [PDF]

Mediterr J Hematol Infect Dis
Molica S, Allsup D.
europepmc   +1 more source

Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety [PDF]

, 1986
O Ayanlar-Batuman, E Ebert, SP Hauptman
openalex   +1 more source

Comprehensive Framework for Oncology Pharmacist‐Led Parenteral Anticancer Therapy Patient Education: The Opinion of the American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
This narrative review summarizes evidence for effective patient education on parenteral anticancer therapies. The authors propose a structured framework for oncology pharmacist‐led patient education on parenteral anticancer therapies that combines pharmacotherapy knowledge and the application of patient‐centered care.
Erin Hickey Zacholski, Jack Dierckes, David Hartnett‐Quach, Cady Noda, Amanda Sharps, Olivia White, Kyle Zacholski, Shawn P. Griffin   +7 more
wiley   +1 more source

Machine Learning Model Predicts Abnormal Lymphocytosis Associated With Chronic Lymphocytic Leukemia. [PDF]

JCO Clin Cancer Inform
Aoki J, Khalid O, Kaya C, Salama ME.
europepmc   +1 more source